help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tagami, T.
Right arrow Articles by Jameson, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tagami, T.
Right arrow Articles by Jameson, J. L.
Molecular Endocrinology 12 (12): 1888-1902
Copyright © 1998 by The Endocrine Society

A Novel Natural Mutation in the Thyroid Hormone Receptor Defines a Dual Functional Domain That Exchanges Nuclear Receptor Corepressors and Coactivators

Tetsuya Tagami, Wen-Xia Gu, Patricia T. Peairs, Brian L. West and J. Larry Jameson

Division of Endocrinology, Metabolism, and Molecular Medicine (T.T., W.-X.G., J.L.J) Northwestern University Medical School Chicago, Illinois 60611
The Baton Rouge Clinic (P.T.P.) Baton Rouge, Louisiana 70806
Metabolic Research Unit (B.L.W.) University of California at San Francisco San Francisco, California 94143

In a patient with severe resistance to thyroid hormone (RTH), we found a novel mutation (leucine to serine in codon 454, L454S) of the thyroid hormone receptor ß. This mutation is in the ligand-dependent transactivation domain that has been shown to interact with transcriptional coactivators (CoAs). The mutant protein binds T3, but its ability to activate transcription of a positively regulated gene (TRE-tk-Luc), and to repress a negatively regulated gene (TSH{alpha}-Luc), is markedly impaired. As anticipated from its location, the L454S mutant interacts weakly with CoAs, such as SRC1 and glucocorticoid receptor interacting protein 1 (GRIP1) in gel mobility shift assays and in mammalian two-hybrid assays, even in the presence of the maximal dose of T3. In contrast, in the absence of T3, the L454S mutant interacts much more strongly with nuclear receptor corepressor (NCoR) than does the wild-type receptor, and the T3-dependent release of NCoR is markedly impaired. By comparison, the NCoR interaction and T3-dependent dissociation of an adjacent AF-2 domain mutant (E457A) are normal. These findings reveal that the Leu 454 is involved directly, or indirectly, in the release of corepressors (CoRs) as well as in the recruitment of CoAs. The strong interaction with NCoR at a physiological concentration of T3 results in constitutive activation of the TSH genes as well as constitutive silencing of positively regulated genes. When the dominant negative effect was examined among various mutants, it correlated surprisingly well with the potency of NCoR binding but not with the degree of impairment in CoA binding. These findings suggest that the defective release of NCoRs, along with retained dimerization and DNA binding, are critical features for the inhibitory action of mutant thyroid hormone receptors. These studies also suggest that helix 12 of the thyroid hormone receptor acts as a dual functional domain. After the binding of T3, its conformation changes, causing the disruption of CoR binding and the recruitment of CoAs.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
M. Alonso, C. Goodwin, X. Liao, T. Ortiga-Carvalho, D. S. Machado, F. E. Wondisford, S. Refetoff, and R. E. Weiss
In Vivo Interaction of Steroid Receptor Coactivator (SRC)-1 and the Activation Function-2 Domain of the Thyroid Hormone Receptor (TR) {beta} in TR{beta} E457A Knock-In and SRC-1 Knockout mice
Endocrinology, August 1, 2009; 150(8): 3927 - 3934.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
T. Tagami, H. Yamamoto, K. Moriyama, K. Sawai, T. Usui, A. Shimatsu, and M. Naruse
The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity
J. Mol. Endocrinol., May 1, 2009; 42(5): 415 - 428.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Tagami, H. Yamamoto, K. Moriyama, K. Sawai, T. Usui, A. Shimatsu, and M. Naruse
A Selective Peroxisome Proliferator-Activated Receptor-{gamma} Modulator, Telmisartan, Binds to the Receptor in a Different Fashion from Thiazolidinediones
Endocrinology, February 1, 2009; 150(2): 862 - 870.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. N. Pessoa, L. A. Santiago, D. A. Santiago, D. S. Machado, F. A. F. Rocha, D. F. Ventura, J. N. Hokoc, C. C. Pazos-Moura, F. E. Wondisford, P. F. Gardino, et al.
Thyroid Hormone Action Is Required for Normal Cone Opsin Expression during Mouse Retinal Development
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2039 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. H. Liu, J. Li, P. Shen, B. Husna, E. S. Tai, and E. L. Yong
A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-{alpha} Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin
Mol. Endocrinol., May 1, 2008; 22(5): 1078 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Moriyama, T. Tagami, T. Usui, M. Naruse, T. Nambu, Y. Hataya, N. Kanamoto, Y.-s. Li, A. Yasoda, H. Arai, et al.
Antithyroid Drugs Inhibit Thyroid Hormone Receptor-Mediated Transcription
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1066 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Y. Wu, R. N. Cohen, E. Simsek, D. A. Senses, N. E. Yar, H. Grasberger, J. Noel, S. Refetoff, and R. E. Weiss
A Novel Thyroid Hormone Receptor-{beta} Mutation That Fails to Bind Nuclear Receptor Corepressor in a Patient as an Apparent Cause of Severe, Predominantly Pituitary Resistance to Thyroid Hormone
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1887 - 1895.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. Michalik, J. N. Feige, L. Gelman, T. Pedrazzini, H. Keller, B. Desvergne, and W. Wahli
Selective Expression of a Dominant-Negative Form of Peroxisome Proliferator-Activated Receptor in Keratinocytes Leads to Impaired Epidermal Healing
Mol. Endocrinol., September 1, 2005; 19(9): 2335 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Lado-Abeal, A. M. Dumitrescu, X.-H. Liao, R. N. Cohen, J. Pohlenz, R. E. Weiss, M.-C. Lebrethon, A. Verloes, and S. Refetoff
A De Novo Mutation in an Already Mutant Nucleotide of the Thyroid Hormone Receptor {beta} Gene Perpetuates Resistance to Thyroid Hormone
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1760 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Danzi and I. Klein
Posttranscriptional regulation of myosin heavy chain expression in the heart by triiodothyronine
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H455 - H460.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
X. Hu, L. Cherbas, and P. Cherbas
Transcription Activation by the Ecdysone Receptor (EcR/USP): Identification of Activation Functions
Mol. Endocrinol., April 1, 2003; 17(4): 716 - 731.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
L. Cherbas, X. Hu, I. Zhimulev, E. Belyaeva, and P. Cherbas
EcR isoforms in Drosophila: testing tissue-specific requirements by targeted blockade and rescue
Development, March 2, 2003; 130(2): 271 - 284.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Moriyama, T. Tagami, T. Akamizu, T. Usui, M. Saijo, N. Kanamoto, Y. Hataya, A. Shimatsu, H. Kuzuya, and K. Nakao
Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5185 - 5190.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Cote, A. Rosenauer, A. Bianchini, K. Seiter, J. Vandewiele, C. Nervi, and W. H. Miller Jr
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells
Blood, September 18, 2002; 100(7): 2586 - 2596.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
I. Dussault, M. Lin, K. Hollister, M. Fan, J. Termini, M. A. Sherman, and B. M. Forman
A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity
Mol. Cell. Biol., August 1, 2002; 22(15): 5270 - 5280.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Marimuthu, W. Feng, T. Tagami, H. Nguyen, J. L. Jameson, R. J. Fletterick, J. D. Baxter, and B. L. West
TR Surfaces and Conformations Required to Bind Nuclear Receptor Corepressor
Mol. Endocrinol., February 1, 2002; 16(2): 271 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K.-h. Lin and Y.-h. Wu shen-liang chen
Impaired Interaction of Mutant Thyroid Hormone Receptors Associated with Human Hepatocellular Carcinoma with Transcriptional Coregulators
Endocrinology, February 1, 2001; 142(2): 653 - 662.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W.-X. Gu, P. H. Stern, L. D. Madison, and G.-G. Du
Mutual Up-Regulation of Thyroid Hormone and Parathyroid Hormone Receptors in Rat Osteoblastic Osteosarcoma 17/2.8 Cells
Endocrinology, January 1, 2001; 142(1): 157 - 164.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Q.-L. Li, E. Jansen, G. A. Brent, and T. C. Friedman
Regulation of prohormone convertase 1 (PC1) by thyroid hormone
Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E160 - E170.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al.
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone
PNAS, November 2, 2000; (2000) 230285997.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Q.-L. Li, E. Jansen, G. A. Brent, S. Naqvi, J. F. Wilber, and T. C. Friedman
Interactions between the Prohormone Convertase 2 Promoter and the Thyroid Hormone Receptor
Endocrinology, September 1, 2000; 141(9): 3256 - 3266.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Lim, F. J. Ghadessy, A. A. R. Abdullah, L. Pinsky, M. Trifiro, and E. L. Yong
Human Androgen Receptor Mutation Disrupts Ternary Interactions between Ligand, Receptor Domains, and the Coactivator TIF2 (Transcription Intermediary Factor 2)
Mol. Endocrinol., August 1, 2000; 14(8): 1187 - 1197.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
S. Oesterreich, Q. Zhang, T. Hopp, S. A. W. Fuqua, M. Michaelis, H. H. Zhao, J. R. Davie, C. K. Osborne, and A. V. Lee
Tamoxifen-Bound Estrogen Receptor (ER) Strongly Interacts with the Nuclear Matrix Protein HET/SAF-B, a Novel Inhibitor of ER-Mediated Transactivation
Mol. Endocrinol., March 1, 2000; 14(3): 369 - 381.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. Gurnell, J. M. Wentworth, M. Agostini, M. Adams, T. N. Collingwood, C. Provenzano, P. O. Browne, O. Rajanayagam, T. P. Burris, J. W. Schwabe, et al.
A Dominant-negative Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) Mutant Is a Constitutive Repressor and Inhibits PPARgamma -mediated Adipogenesis
J. Biol. Chem., February 25, 2000; 275(8): 5754 - 5759.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Busch, B. Martin, A. Baniahmad, J. A. Martial, R. Renkawitz, and M. Muller
Silencing Subdomains of v-ErbA Interact Cooperatively with Corepressors: Involvement of Helices 5/6
Mol. Endocrinol., February 1, 2000; 14(2): 201 - 211.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
P.-Y. Chien, M. Ito, Y. Park, T. Tagami, B. D. Gehm, and J. L. Jameson
A Fusion Protein of the Estrogen Receptor (ER) and Nuclear Receptor Corepressor (NCoR) Strongly Inhibits Estrogen-Dependent Responses in Breast Cancer Cells
Mol. Endocrinol., December 1, 1999; 13(12): 2122 - 2136.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Pohlenz, R. E. Weiss, P. E. Macchia, S. Pannain, I. T. Lau, H. Ho, and S. Refetoff
Five New Families with Resistance to Thyroid Hormone not Caused by Mutations in the Thyroid Hormone Receptor {beta} Gene
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3919 - 3928.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Tagami, Y. Park, and J. L. Jameson
Mechanisms That Mediate Negative Regulation of the Thyroid-stimulating Hormone alpha Gene by the Thyroid Hormone Receptor
J. Biol. Chem., August 6, 1999; 274(32): 22345 - 22353.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. Davis, A. Shih, H.-Y. Lin, L. J. Martino, and F. B. Davis
Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR
J. Biol. Chem., November 22, 2000; 275(48): 38032 - 38039.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. N. Collingwood, F. D. Urnov, V. K. K. Chatterjee, and A. P. Wolffe
Chromatin Remodeling by the Thyroid Hormone Receptor in Regulation of the Thyroid-stimulating Hormone alpha -Subunit Promoter
J. Biol. Chem., August 31, 2001; 276(36): 34227 - 34234.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D.-J. Jung, S.-K. Lee, and J. W. Lee
Agonist-dependent Repression Mediated by Mutant Estrogen Receptor alpha That Lacks the Activation Function 2 Core Domain
J. Biol. Chem., September 28, 2001; 276(40): 37280 - 37283.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, K. Kaneshige, X.-g. Zhu, A. Dace, L. Garrett, T. A. Carter, R. Kazlauskaite, D. G. Pankratz, A. Wynshaw-Boris, S. Refetoff, et al.
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone
PNAS, November 21, 2000; 97(24): 13209 - 13214.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society